N-(5-tert-butyl-3-isoxazolyl)-2-chloroacetamide, 95.0%, 1g

2,4-difluoro-5-iodopyridine, 95+%, 10g

2-Bromo-3-(trifluoromethyl)benzoic acid, 95.0%, 25g

3-((Benzyloxy)methyl)-4-ethyl-1H-1,2,4-triazol-5(4H)-one, 98%, 1g

(1S,2S)-(+)-1-Amino-2-indanol>98.0%(GC)5g

1-Octadecene, 90.0%, 100g

4-((5-Amino-1-(2,6-difluorobenzoyl)-1H-1,2,4-triazol-3-yl)amino)benzenesulfonamide, 95.0%, 50mg

3-Methyl-4-oxo-3,4-dihydroimidazo[5,1-d][1,2,3,5]tetrazine-8-carboxamide, 95.0%, 250mg

Screw vials conical sterile, 0.5 ml, 200 Piece(s)

Ethyl 4-hydroxy-3-oxobutanoate, 97%, 1g

4'-Hydroxy-[1,1'-biphenyl]-3-carbonitrile, 95.0%, 1g

N-Tigloylglycine>98.0%(T)100mg

2-(Perfluorobutyl)ethyl acrylate, 97.0%, 1g